Miracure Biotechnology
- Biotech or pharma, therapeutic R&D
Our leading asset is a broad spectrum, oral antiviral Nucleotide Prodrug in IND enabling. We have epigenetic degrader/immune activator both oral and conjugated at preclinical. We are actively seeking outlicensing partnership for pipeline and technology
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}